HOME Top Market Reports In Vitro Diagnostics (IVD) Quality Control Market by Application (Immunoassay, Molecular Diagnostics, Microbiology, Hemostasis, Hematology), Source (Serum, Whole Blood, Urine), Type (Instrument Specific, Third Party Control) - Global Forecast to 2022

In Vitro Diagnostics (IVD) Quality Control Market by Application (Immunoassay, Molecular Diagnostics, Microbiology, Hemostasis, Hematology), Source (Serum, Whole Blood, Urine), Type (Instrument Specific, Third Party Control) - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: July 2017
Report Code: MD 4180

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global IVD Quality Controls Market is expected to reach USD 1.04 Billion by 2022, at a CAGR of 3.5% from 2017 to 2022. Growth in the global In Vitro Diagnostics Quality Controls Market is mainly driven by factors such as the increasing number of accredited clinical laboratories and growing adoption of third-party quality controls to ensure unbiased test results. Moreover, the increasing use of multi-analyte controls and increasing focus of key players on emerging countries are creating new growth opportunities for this market. However, uncertainty in reimbursement and lack of regulations are restraining the growth of the market.

This report aims to estimate the market size and future growth potential of the IVD Quality Controls Market across different segments such as product and service, application, manufacturer type, end user, and region. The third-party quality controls segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing use of third-party quality controls across the globe to verify patient test results.

Geographically, North America dominated the global IVD quality control products market in 2016. The large share of this region can be attributed to greater accessibility to advanced technologies, improved healthcare infrastructure, established distribution channels, and presence of various leading market players such as Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Abbott Laboratories, Inc. (U.S.), and Danaher Corporation (U.S.). However, the Asia-Pacific region is expected to be the fastest-growing market during the forecast period.

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global IVD Quality Controls Market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research, and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data is consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

In Vitro Diagnostics (IVD) Quality Control Market

To know about the assumptions considered for the study, download the pdf brochure

The key players in this market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Randox Laboratories (U.K.), Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Siemens Healthcare (Germany), and Sysmex Corporation (Japan).

Target Audience

  • IVD product manufacturers
  • Group purchase organizations (GPOs)
  • OEM manufacturers
  • Pathologists and pathology laboratories
  • Distributors of IVD quality control products
  • Hospitals and clinics
  • Healthcare institutions
  • Research institutes
  • Market research and consulting firms
  • Venture capitalists and investors

Scope of the Report

This research report categorizes the global In Vitro Diagnostics Quality Controls Market into the following segments:

IVD Quality Controls Market, By Product and Service

  • Quality Control Products
    • Serum/Plasma-based Products
    • Whole Blood-based Products
    • Urine-based Products
    • Other Quality Control Products
  • Data Management Solutions
  • Quality Assurance Services

IVD Quality Controls Market, By Application

  • Clinical Chemistry
  • Immunochemistry
  • Hematology
  • Molecular Diagnostics
  • Coagulation/Hemostasis
  • Microbiology
  • Other Applications

IVD Quality Controls Market, By End User

  • Hospitals
  • Laboratories
  • Research Institutes and Academic Institutes
  • Other End Users

IVD Quality Controls Market, By Manufacturer Type

  • Third-party Control Manufacturers
    • Independent Manufacturer Controls
    • Instrument Specific Controls
  • OEMs

IVD Quality Controls Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLA)
  • Middle East and Africa

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Market Size Analysis

  • Further breakdown of the Rest of Asia-Pacific IVD market in South Korea, Australia, New Zealand, and other countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 23)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 30)

4 Premium Insights (Page No. - 36)
    4.1 in Vitro Diagnostics (IVD ) Quality Controls: Market Overview
    4.2 Asia-Pacific: IVD Quality Controls Market, By Type
    4.3 Geographic Snapshot of the In Vitro Diagnostics Quality Controls Market 
    4.4 Geographic Mix 
    4.5 Global Market: Developing vs Developed Markets

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Growing Number of Accredited Clinical Laboratories
                    5.2.1.2 Growing Adoption of Third-Party Quality Controls
                    5.2.1.3 Growing Demand for External Quality Assessment (EQA) Support
           5.2.2 Market Restraints
                    5.2.2.1 Additional Costs Involved in Quality Control and Budget Constraints in Hospitals and Laboratories
                    5.2.2.2 Unfavorable Reimbursement Scenario for IVD Tests
           5.2.3 Market Opportunities
                    5.2.3.1 Rising Demand for Multi-Analyte Controls
           5.2.4 Challenges
                    5.2.4.1 Stringent Product Approval Process
                    5.2.4.2 Lack of Mandatory Regulations for Clinical Laboratory Accreditations in Several Emerging Countries

6 Industry Insights (Page No. - 49)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Growing Adoption of Third-Party Quality Controls
           6.2.2 Increasing Focus of Customers Towards the Use of External Quality Assurance Support From Manufacturers
    6.3 Porter’s Five Force Analysis
           6.3.1 Threat of New Entrants
           6.3.2 Threat of Substitutes
           6.3.3 Bargaining Power of Suppliers
           6.3.4 Bargaining Power of Buyers
           6.3.5 Intensity of Competitive Rivalry
    6.4 Regulatory Analysis
           6.4.1 North America
                    6.4.1.1 U.S.
                    6.4.1.2 Canada
           6.4.2 Europe
           6.4.3 Asia-Pacific
                    6.4.3.1 Japan
                    6.4.3.2 China
                    6.4.3.3 India

7 Global IVD Quality Controls Market, By Product and Service (Page No. - 58)
    7.1 Introduction
    7.2 Quality Control Products
           7.2.1 Whole-Blood-Based Controls
           7.2.2 Serum/Plasma-Based Controls
           7.2.3 Urine-Based Controls
           7.2.4 Other IVD Quality Controls
    7.3 Data Management Solutions
    7.4 Quality Assurance Services

8 Global IVD Quality Controls Market, By Application (Page No. - 71)
    8.1 Introduction
    8.2 Immunochemistry
    8.3 Clinical Chemistry
    8.4 Hematology
    8.5 Molecular Diagnostics
    8.6 Coagulation/Hemostasis
    8.7 Microbiology
    8.8 Other Applications

9 IVD Quality Controls Market, By Manufacturer Type (Page No. - 84)
    9.1 Introduction
    9.2 Third-Party Control Manufacturers
            9.2.1 Independent Manufacturer Controls
            9.2.2 Instrument-Specific Controls
    9.3 OEMS

10 Global IVD Quality Controls Market, By End User (Page No. - 92)
     10.1 Introduction
     10.2 Hospitals
     10.3 Clinical Laboratories
     10.4 Research and Academic Institutes
     10.5 Other End Users

11 Geographic Analysis (Page No. - 100)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 U.K.
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe (RoE)
     11.4 Asia-Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of Asia-Pacific
     11.5 Latin America
             11.5.1 Brazil
                        11.5.1.1 Mexico
                        11.5.1.2 Rest of Latin America
             11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. - 138)
     12.1 Introduction
     12.2 Visionary Leaders
     12.3 Innovators
     12.4 Emerging Companies
     12.5 Dynamic Differentiators
     12.6 Competitive Benchmarking
             12.6.1 Product Offerings
             12.6.2 Business Strategy
     12.7 Market Share Analysis

13 Company Profiles (Page No. - 146)
     13.1 Bio-Rad Laboratories, Inc.
             13.1.1 Business Overview
             13.1.2 Products Offered
             13.1.3 Product/Service Offering Scorecard
Bio-Rad Laboratories Offers External Quality Assurance Services (EQAS) and Educational Programs in Order to Improve Laboratory Diagnostic Performance.
             13.1.4 Business Strategy Scorecard
             13.1.5 Recent Developments
                        13.1.5.1 Product Launches and Enhancements
                        13.1.5.2 Contracts
     13.2 Roche Diagnostics
             13.2.1 Business Overview
             13.2.2 Products Offered
             13.2.3 Product/Service Offerings Scorecard
             13.2.4 Business Strategy Scorecard
             13.2.5 Recent Developments
                        13.2.5.1 Expansions
     13.3 Abbott Laboratories Inc.
             13.3.1 Business Overview
             13.3.2 Products Offered
             13.3.3 Product Offerings Scorecard
             13.3.4 Business Strategy Scorecard
             13.3.5 Recent Developments
                        13.3.5.1 Agreements
     13.4 Thermo Fisher Scientific Inc.
             13.4.1 Business Overview
             13.4.2 Products Offered
             13.4.3 Product Offerings Scorecard
             13.4.4 Business Strategy Scorecard
             13.4.5 Recent Developments
                        13.4.5.1 Product Launches and Enhancements
                        13.4.5.2 Partnerships
                        13.4.5.3 Expansions
                        13.4.5.4 164
     13.5 Helena Laboratories
             13.5.1 Business Overview
             13.5.2 Products Offered
             13.5.3 Product/Service Offerings Scorecard
             13.5.4 Business Strategy Scorecard
     13.6 Seracare Life Sciences, Inc.
             13.6.1 Business Overview
             13.6.2 Products Offered
             13.6.3 Product Offerings Scorecard
             13.6.4 Business Strategy Scorecard
             13.6.5 Recent Developments
                        13.6.5.1 Product Launches
                        13.6.5.2 Agreements and Partnerships
                        13.6.5.3 Acquisitions
     13.7 Sero as
             13.7.1 Business Overview
             13.7.2 Products Offered
             13.7.3 Product Offerings Scorecard
             13.7.4 Business Strategy Scorecard
             13.7.5 Recent Developments
                        13.7.5.1 Product Launches
     13.8 Randox Laboratories Ltd.
             13.8.1 Business Overview
             13.8.2 Products Offered
             13.8.3 Product Offerings Scorecard
             13.8.4 Business Strategy Scorecard
             13.8.5 Recent Developments
                        13.8.5.1 Product Launches and Approvals
     13.9 Siemens AG
             13.9.1 Business Overview
             13.9.2 Services Offered
             13.9.3 Product Offering Scorecard
             13.9.4 Business Strategy Scorecard
             13.9.5 Recent Developments
                        13.9.5.1 Product Enhancements
     13.10 Technopath Clinical Diagnostics
             13.10.1 Business Overview
             13.10.2 Products Offered
             13.10.3 Product Offerings Scorecard
             13.10.4 Business Strategy Scorecard
             13.10.5 Recent Developments
                        13.10.5.1 Product Launches and Approvals
                        13.10.5.2 Acquisitions
                        13.10.5.3 Expansions
     13.11 Ortho Clinical Diagnostics, Inc.
             13.11.1 Business Overview
             13.11.2 Products Offered
     13.12 Sun Diagnostics, LLC
             13.12.1 Business Overview
             13.12.2 Products Offered
             13.12.3 Product Offerings Scorecard
             13.12.4 Business Strategy Scorecard
             13.12.5 Recent Developments
                        13.12.5.1 Agreements

14 Appendix (Page No. - 192)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Introducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports


List of Tables (162 Tables)

Table 1 Global In Vitro Diagnostics Quality Controls Market Snapshot
Table 2 Market Drivers: Impact Analysis
Table 3 Number of Accredited Medical Laboratories in Europe, 2011-2014
Table 4 Number of Accredited Medical Laboratories in Japan, Australia, India, and Canada, June 2011-March 2015
Table 5 Market Restraints: Impact Analysis
Table 6 Market Opportunities: Impact Analysis
Table 7 Market Challenges: Impact Analysis
Table 8 U.S.: Classification of Quality Control Material
Table 9 Canada: Classification of IVD Products
Table 10 Accreditation Bodies for Quality Systems for Medical Laboratories in Europe
Table 11 IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 12 Global IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 13 Global IVD Quality Control Products Market Size, By Country, 2015–2022 (USD Million)
Table 14 Whole-Blood-Based Quality Control Offerings By Key Market Players
Table 15 Global Whole-Blood-Based Quality Controls Market Size, By Country, 2015–2022 (USD Million)
Table 16 Serum/Plasma-Based Quality Control Offerings By Key Market Players
Table 17 Global Serum/Plasma-Based Quality Controls Market Size, By Country, 2015–2022 (USD Million)
Table 18 Urine-Based Quality Control Offerings By Key Market Players
Table 19 Global Urine-Based Quality Controls Market Size, By Country, 2015–2022 (USD Million)
Table 20 Spinal Fluid-Based Quality Control Offerings By Key Market Players
Table 21 Global Other In Vitro Diagnostics Quality Controls Market Size, By Country, 2015–2022 (USD Million)
Table 22 Data Management Solution Offerings By Key Market Players
Table 23 Global IVD Quality Control Data Management Solutions Market Size, By Country, 2015–2022 (USD Million)
Table 24 Quality Assurance Services Offerings By Key Market Players
Table 25 Global IVD Quality Assurance Services Market Size, By Country, 2015–2022 (USD Million)
Table 26 Global IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 27 Global In Vitro Diagnostics Quality Controls Market Size for Immunochemistry, By Country, 2015–2022 (USD Million)
Table 28 Global Market Size for Clinical Chemistry, By Country, 2015–2022 (USD Million)
Table 29 Global In Vitro Diagnostics Quality Controls Market Size for Hematology, By Country, 2015–2022 (USD Million)
Table 30 Global Market Size for Molecular Diagnostics, By Country, 2015–2022 (USD Million)
Table 31 Global IVD Quality Controls Market Size for Coagulation/Hemostasis, By Country, 2015–2022 (USD Million)
Table 32 Global In Vitro Diagnostics Quality Controls Market Size for Microbiology, By Country, 2015–2022 (USD Million)
Table 33 Global Quality Controls Market Size for Other Applications, By Country, 2015–2022 (USD Million)
Table 34 Global Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 35 Global Third-Party Quality Controls Market Size, By Type, 2015–2022 (USD Million)
Table 36 Global Third-Party Quality Controls Market Size, By Country, 2015–2022 (USD Million)
Table 37 Global Independent Manufacturer Controls Market Size, By Country, 2015–2022 (USD Million)
Table 38 Global Instrument-Specific Controls Market Size, By Country, 2015–2022 (USD Million)
Table 39 Global Oem Manufacturer Controls Market Size, By Country, 2015–2022 (USD Million)
Table 40 Global IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 41 Global In Vitro Diagnostics Quality Controls Market Size for Hospitals, By Country, 2015–2022 (USD Million)
Table 42 Global IVD Quality Controls Market Size for Clinical Laboratories, By Country, 2015–2022 (USD Million)
Table 43 Global Market Size for Research and Academic Institutes, By Country, 2015–2022 (USD Million)
Table 44 Global IVD Quality Controls Market Size for Other End Users, By Country, 2015–2022 (USD Million)
Table 45 Global IVD Quality Control Products Market Size, By Region, 2015–2022 (USD Million)
Table 46 Global IVD Quality Control Products Market Size, By Country, 2015–2022 (USD Million)
Table 47 North America: IVD Quality Control Products Market Size, By Country, 2015–2022 (USD Million)
Table 48 North America: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 49 North America: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 50 North America: IVD Quality Controls Market Market Size, By Application, 2015–2022 (USD Million)
Table 51 North America: Market Size, By End User, 2015–2022 (USD Million)
Table 52 North America: In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 53 U.S.: Macroeconomic Indicators
Table 54 U.S.: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 55 U.S.: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 56 U.S.: Market Size, By Application, 2015–2022 (USD Million)
Table 57 U.S.: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 58 U.S.: Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 59 Canada: Macroeconomic Indicators
Table 60 Canada: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 61 Canada: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 62 Canada: Market Size, By Application, 2015–2022 (USD Million)
Table 63 Canada: IVD Quality Controls Market Market Size, By End User, 2015–2022 (USD Million)
Table 64 Canada: Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 65 Europe: IVD Quality Control Products Market Size, By Country, 2015–2022 (USD Million)
Table 66 Europe: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 67 Europe: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 68 Europe: Market Size, By Application, 2015–2022 (USD Million)
Table 69 Europe: In Vitro Diagnostics Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 70 Europe: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 71 Germany: Macroeconomic Indicators
Table 72 Germany: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 73 Germany: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 74 Germany: Market Size, By Application, 2015–2022 (USD Million)
Table 75 Germany: Market Size, By End User, 2015–2022 (USD Million)
Table 76 Germany: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 77 France: Macroeconomic Indicators
Table 78 France: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 79 France: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 80 France: Market Size, By Application, 2015–2022 (USD Million)
Table 81 France: In Vitro Diagnostics Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 82 France: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 83 U.K.: Macroeconomic Indicators
Table 84 U.K.: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 85 U.K.: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 86 U.K.: Market Size, By Application, 2015–2022 (USD Million)
Table 87 U.K.: IVD Quality Controls Market Market Size, By End User, 2015–2022 (USD Million)
Table 88 U.K.: Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 89 Italy: Macroeconomic Indicators
Table 90 Italy: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 91 Italy: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 92 Italy: Market Size, By Application, 2015–2022 (USD Million)
Table 93 Italy: Market Size, By End User, 2015–2022 (USD Million)
Table 94 Italy: In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 95 Spain: Macroeconomic Indicators
Table 96 Spain: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 97 Spain: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 98 Spain: Market Size, By Application, 2015–2022 (USD Million)
Table 99 Spain: IVD Quality Controls Market Market Size, By End User, 2015–2022 (USD Million)
Table 100 Spain: In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 101 RoE: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 102 RoE: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 103 RoE: Market Size, By Application, 2015–2022 (USD Million)
Table 104 RoE: IVD Quality Controls Market Market Size, By End User, 2015–2022 (USD Million)
Table 105 RoE: Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 106 APAC: IVD Quality Control Products Market Size, By Country, 2015–2022 (USD Million)
Table 107 APAC: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 108 APAC: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 109 APAC: Market Size, By Application, 2015–2022 (USD Million)
Table 110 APAC: IVD Quality Controls Market Market Size, By End User, 2015–2022 (USD Million)
Table 111 APAC: In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 112 Japan: Macroeconomic Indicators
Table 113 Japan: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 114 Japan: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 115 Japan: Market Size, By Application, 2015–2022 (USD Million)
Table 116 Japan: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 117 Japan: Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 118 China: Macroeconomic Indicators
Table 119 China: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 120 China: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 121 China: Market Size, By Application, 2015–2022 (USD Million)
Table 122 China: IVD Quality Controls Market Market Size, By End User, 2015–2022 (USD Million)
Table 123 China: Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 124 India: Macroeconomic Indicators
Table 125 India: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 126 India: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 127 India: In Vitro Diagnostics Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 128 India: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 129 India: In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 130 RoAPAC: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 131 RoAPAC: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 132 RoAPAC: Market Size, By Application, 2015–2022 (USD Million)
Table 133 RoAPAC: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 134 RoAPAC: Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 135 Latin America: IVD Quality Control Products Market Size, By Country, 2015–2022 (USD Million)
Table 136 Latin America: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 137 Latin America: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 138 Latin America: Market Size, By Application, 2015–2022 (USD Million)
Table 139 Latin America: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 140 Latin America: Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 141 Brazil: Macroeconomic Indicators
Table 142 Brazil: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 143 Brazil: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 144 Brazil: In Vitro Diagnostics Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 145 Brazil: IVD Quality Control Products Market Size, By End User, 2015–2022 (USD Million)
Table 146 Brazil: IVD Quality Control Products Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 147 Mexico: Macroeconomic Indicators
Table 148 Mexico: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 149 Mexico: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 150 Mexico: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 151 Mexico: In Vitro Diagnostics Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 152 Mexico: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 153 RoLA: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 154 RoLA: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 155 RoLA: Market Size, By Application, 2015–2022 (USD Million)
Table 156 RoLA: IVD Quality Controls Market Market Size, By End User, 2015–2022 (USD Million)
Table 157 RoLA: Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 158 Middle East and Africa: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 159 Middle East and Africa: IVD Quality Controls Market Size, By Source Type, 2015–2022 (USD Million)
Table 160 Middle East and Africa: Market Size, By Application, 2015–2022 (USD Million)
Table 161 Middle East and Africa: Market Size, By End User, 2015–2022 (USD Million)
Table 162 Middle East and Africa: In Vitro Diagnostics Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)


List of Figures (36 Figures)

Figure 1 Global IVD Quality Controls Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global IVD Quality Controls Market, By Product and Service, 2017 vs 2022 (USD Million)
Figure 7 Global IVD Quality Controls Market, By Source, 2017 vs 2022 (USD Million)
Figure 8 Global IVD Quality Controls Market, By Manufacturer Type, 2017 vs 2022 (USD Million)
Figure 9 Global Third-Party Quality Controls Market, By Type, 2017 vs 2022 (USD Million)
Figure 10 Global IVD Quality Controls Market, By End User, 2017 vs 2022 (USD Million)
Figure 11 Global IVD Quality Controls Market, By Application, 2017 vs 2022 (USD Million)
Figure 12 IVD Quality Controls Market: Geographic Snapshot
Figure 13 Rising Adoption of Third-Party Quality Controls is Driving Growth of the IVD Quality Controls Market
Figure 14 Serum/Plasma-Based Controls to Account for the Largest Share of the IVD Quality Controls Market in Asia-Pacific
Figure 15 The U.S. Accounted for Largest Share of the IVD Quality Controls Market in 2016
Figure 16 APAC to Grow at the Highest CAGR in the Forecast Period
Figure 17 Developing Markets to Register A Higher Growth During the Forecast Period
Figure 18 IVD Quality Controls Market: Drivers, Restraints, Opportunities, & Challenges
Figure 19 Number of Laboratories Participating in EQA Programs in Brazil, 2010-2016
Figure 20 Quality Control Products Segment to Witness the Highest Growth During the Forecast Period
Figure 21 Molecular Diagnostics is Expected to Register the Highest CAGR During the Forecast Period of 2017–2022
Figure 22 Third-Party Controls Segment to Witness Highest Growth During the Forecast Period
Figure 23 Clinical Laboratories is the Fastest Growing End-User Segment of the IVD Quality Controls Market During the Forecast Period
Figure 24 North America to Dominate the IVD Quality Control Products Market
Figure 25 Market Overview: North America
Figure 26 European IVD Quality Controls Market Overview
Figure 27 Accredited Clinical Laboratories in Mexico: 2005-2015
Figure 28 Competitive Leadership Mapping
Figure 29 Global in Vitro Diagnostics Quality Controls Market Share Analysis, By Key Player, 2016
Figure 30 Bio-Rad Laboratories, Inc.: Company Snapshot (2016)
Figure 31 Roche Diagnostics: Company Snapshot (2016)
Figure 32 Abbott Laboratories Inc.: Company Snapshot (2016)
Figure 33 Thermo Fisher Scientific, Inc.: Company Snapshot (2016)
Figure 34 Siemens AG: Company Snapshot (2016)
Figure 35 Marketsandmarkets Knowledge Store Snapshot
Figure 36 Healthcare Industry Snapshot

The global in vitro diagnostics (IVD) quality controls market is estimated to reach USD 1.04 Billion by 2022, growing at a CAGR of 3.5% during the forecast period of 2017 to 2022. This market is mainly driven by the growing number of accredited clinical laboratories across the globe and growing need to ensure the accuracy of the diagnostic test results. However, the increasing use of multi-analyte quality controls is expected to offer lucrative growth opportunities to market players.

In this report, the market is segmented on the basis of product and service, application, manufacturer type, end user, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global IVD quality controls market and its submarkets.

Based on product and service, the market is segmented into quality controls, data management solutions, and quality assurance services. The quality controls segment accounted for the largest share of the market in 2016, and is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the increasing availability & demand for technologically advanced quality control materials with greater stability.

On the basis of application, the In Vitro Diagnostics Quality Controls Market is segmented into the clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation/hemostasis, microbiology, and other applications. The immunochemistry segment accounted for the largest share of the In Vitro Diagnostics Quality Controls Market in 2016. This is mainly due to the increasing number of multi-analyte controls to perform immunoassay tests. The molecular diagnostics segment is expected to grow at highest CAGR during the forecast period, mainly due to the increasing number of molecular diagnostic tests performed in laboratories and need to ensure the accuracy of these complex diagnostic tests.

In this report, the global IVD quality controls market is studied at the regional and country levels. In 2016, North America represented the largest regional market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Although, North America will continue to dominate the global In Vitro Diagnostics Quality Controls Market during the forecast period, the Asia-Pacific region is expected to be the fastest-growing geographic market in the coming years. A majority of the growth in this region is driven by the rapid growth in the number of accredited laboratories and increasing use of quality control products by the clinical laboratories in this region.

In Vitro Diagnostics (IVD) Quality Control Market

Some of the factors such as unfavourable reimbursement scenario for IVD tests, additional costs involved in the quality control process, and budget constraints in hospitals and laboratories are expected to restrain the growth of this market during the forecast period.

Major players in this market are continuously focusing on securing higher market shares through product launches, expansions, agreements, partnerships, and acquisitions. The major players in the global IVD quality controls market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Randox Laboratories (U.K.), Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Siemens Healthcare (Germany), and Sysmex Corporation (Japan).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth In-Vitro Diagnostics Markets on KnowledgeStore
Request Demo